Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03638999 · ClinicalTrials.gov registry record · Early Phase 1
NSAIDs Stent Study
A Early Phase 1 study of Kidney Stone and Ureteral Stent Placement, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT03638999 is a Early Phase 1 study of Kidney Stone and Ureteral Stent Placement that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 36 participants, below the 192-participant average among 28 other Kidney Stone trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03638999, a Early Phase 1 study of Kidney Stone and Ureteral Stent Placement, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to (1) evaluate the effect of Ketorolac on inflammatory response and its impact on stent related symptoms in patients undergoing stent placement procedure and (2) assess feasibility of recruitment, randomization, assessment procedures and implementation of the study intervention.
Conditions Studied
Interventions
- DRUG Normal saline
- DRUG Ketorolac Trometamol 30Mg/1mL Injection
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2027-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03638999
The ClinicalTrials.gov registry entry for NCT03638999 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 192-participant average among 28 other Kidney Stone trials with a reported enrollment target (81% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Kidney Stone appearing as the primary indexed condition, and to 2 interventions - of which Normal saline is the first listed.
NCT03638999 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT03638999 about?
NCT03638999 is a clinical study titled "NSAIDs Stent Study". This is a pilot study to (1) evaluate the effect of Ketorolac on inflammatory response and its impact on stent related symptoms in patients undergoing stent placement procedure and (2) assess feasibility of recruitment, randomization, assessment procedures and implementation of the study interventio...
What is the current status of trial NCT03638999?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 36 participants. The study started on 2018-07-31. Estimated completion is 2027-10.
What conditions does trial NCT03638999 study?
This clinical trial studies the following conditions: Kidney Stone, Ureteral Stent Placement.
What interventions are being tested in trial NCT03638999?
The interventions under investigation include: Normal saline (DRUG), Ketorolac Trometamol 30Mg/1mL Injection (DRUG).
Who is sponsoring clinical trial NCT03638999?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03638999 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
RECRUITING · NA
-
Access Sheath and Stent Trial
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.